Ischemia reperfusion injury facilitates lung allograft acceptance through IL-33-mediated activation of donor-derived IL-5 producing group 2 innate lymphoid cells is a research paper published in American Journal of Transplantation (2022). On theSindex it has a DataRank of 0. It has been cited 21 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart, Lung, and Blood Institute
Grant: R01HL094601
National Heart, Lung, and Blood Institute
Grant: R01HL151078
National Institute of Allergy and Infectious Diseases
Grant: P01 AI116501
National Institute of Allergy and Infectious Diseases
Grant: R01 AI145108-01
BLRD VA
Grant: I01 BX002299
NHLBI NIH HHS
Grant: R01 HL166402
NIAID NIH HHS
Grant: R01 AI145108
National Institutes of Health
Grant: 5P01AI116501-04
Pathways Regulating Lung Transplant Tolerance
National Institutes of Health
Grant: 2R01AI145108-07
The Role of Donor-Derived Eosinophils on Lung Allograft Ischemia Reperfusion Injury
National Institutes of Health
Grant: 2R01HL094601-14A1
The Role of Ischemia Reperfusion Injury in Lung Allograft Rejection
National Institutes of Health
Grant: 5R01HL151078-02
The Role of Donor Innate Immune Responses in Regulating Alloimmunity after Heart Transplantation
National Institutes of Health
Grant: 5I01BX002299-02
Mechanisms of Immunosurveillance for Lung Cancer
Fields of Study
MeSH Terms
Keywords